• DRAMP ID

    • DRAMP18083
    • Sequence

    • (CKPV)2
    • Sequence Name

    • CZEN-002
    • Description

    • synthetic 8-mer derived from α-melanocyte-stimulating hormone
    • Activity

    • anti-candidal
    • Medical use

    • Vulvovaginal candidiasis
    • Stage of Development

    • Phase IIb
    • Comments

    • Positive efficacy results announced. Phase IIb trial is a dose-ranging study
    • Company

    • Zengen(Woodland Hills, CA, USA)
    • Target Organism

      • No MICs found on DRAMP database
    • Reference

      • Antimicrobial peptides: therapeutic potential. Expert Opin. Pharmacother. (2006).